Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors.

Circulating cytokines and growth factors are regulators of inflammation and have been implicated in autoimmune and metabolic diseases. In this genome-wide association study (GWAS) of up to 8,293 Finns we identified 27 genome-widely significant loci (p < 1.2 × 10-9) for one or more cytokines. Fifteen of the associated variants had expression quantitative trait loci in whole blood. We provide genetic instruments to clarify the causal roles of cytokine signaling and upstream inflammation in immune-related and other chronic diseases. We further link inflammatory markers with variants previously associated with autoimmune diseases such as Crohn disease, multiple sclerosis, and ulcerative colitis and hereby elucidate the molecular mechanisms underpinning these diseases and suggest potential drug targets.

[1]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[2]  Andre Franke,et al.  1000 Genomes-based imputation identifies novel and refined associations for the Wellcome Trust Case Control Consortium phase 1 Data , 2012, European Journal of Human Genetics.

[3]  F. Hu,et al.  Genome-Wide Association Study Identifies Variants at the IL18-BCO2 Locus Associated With Interleukin-18 Levels , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[4]  Lourdes P Norman,et al.  Deletion of the Mouse Meprin β Metalloprotease Gene Diminishes the Ability of Leukocytes to Disseminate through Extracellular Matrix1 , 2004, The Journal of Immunology.

[5]  Daniel Rios,et al.  Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .

[6]  Gavin Giovannoni,et al.  Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial , 2013, The Lancet.

[7]  Glinda S Cooper,et al.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. , 2009, Journal of autoimmunity.

[8]  E. Thorsby,et al.  Linkage disequilibrium and haplotype blocks in the MHC vary in an HLA haplotype specific manner assessed mainly by DRB1*03 and DRB1*04 haplotypes , 2006, Genes and Immunity.

[9]  J. Marchini,et al.  Genotype imputation for genome-wide association studies , 2010, Nature Reviews Genetics.

[10]  R. Homer,et al.  Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung , 2004, Nature Medicine.

[11]  A genome-wide expression quantitative trait loci analysis of proprotein convertase subtilisin/kexin enzymes identifies a novel regulatory gene variant for FURIN expression and blood pressure , 2015, Human Genetics.

[12]  S. Kanazawa,et al.  VEGF, basic-FGF, and TGF-β in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation , 2001, American Journal of Gastroenterology.

[13]  S. Kanazawa,et al.  VEGF, basic-FGF, and TGF-β in Crohn’s disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation , 2001 .

[14]  G. Krishnamoorthy,et al.  Interferon β‐1a reduces increased interleukin‐16 levels in multiple sclerosis patients , 2014, Acta neurologica Scandinavica.

[15]  M. Weiner,et al.  Influence of Genetic Variation on Plasma Protein Levels in Older Adults Using a Multi-Analyte Panel , 2013, PloS one.

[16]  J. Ahluwalia.  Immunotherapy in inflammatory bowel disease. , 2012, The Medical clinics of North America.

[17]  K. Metzner,et al.  HIV suppression by interleukin-16 , 1995, Nature.

[18]  R. Fleming,et al.  A time-course analysis of mRNA expression during injury healing in human dermal injuries , 2014, International Journal of Legal Medicine.

[19]  C. Akdis,et al.  Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. , 2011, The Journal of allergy and clinical immunology.

[20]  Manuel A. R. Ferreira,et al.  Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis , 2015, The lancet. Diabetes & endocrinology.

[21]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[22]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[23]  C. Chitnis,et al.  A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. , 1993, Science.

[24]  H. Rabb,et al.  Stem cell factor, interleukin-16, and interleukin-2 receptor alpha are predictive biomarkers for delayed and slow graft function. , 2010, Transplantation proceedings.

[25]  Tariq Ahmad,et al.  Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study , 2016, The Lancet.

[26]  J. Rioux.  International Inflammatory Bowel Disease Genetics Consortium Identifies >50 Genetic Risk Factors for Ulcerative Colitis , 2010 .

[27]  Tariq Ahmad,et al.  Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 , 2011, Nature Genetics.

[28]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[29]  M. Weisman,et al.  Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. , 2003, Arthritis and rheumatism.

[30]  Matti Pirinen,et al.  FINEMAP: Efficient variable selection using summary data from genome-wide association studies , 2015 .

[31]  J. Dvorak,et al.  Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. , 1975, Science.

[32]  S. Bandinelli,et al.  Novel gene variants predict serum levels of the cytokines IL-18 and IL-1ra in older adults. , 2014, Cytokine.

[33]  C. Gieger,et al.  Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. , 2010, Blood.

[34]  L. Bierut,et al.  Novel Genetic Locus Implicated for HIV-1 Acquisition with Putative Regulatory Links to HIV Replication and Infectivity: A Genome-Wide Association Study , 2015, PloS one.

[35]  Liam G. Fearnley,et al.  The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection. , 2015, Cell systems.

[36]  G. Davey Smith,et al.  Mendelian randomization: genetic anchors for causal inference in epidemiological studies , 2014, Human molecular genetics.

[37]  Peggy Hall,et al.  The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..

[38]  Akira Meguro,et al.  Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1 , 2013, Nature Genetics.

[39]  M. Neurath,et al.  Both IL‐12p70 and IL‐23 are synthesized during active Crohn's disease and are down‐regulated by treatment with anti‐IL‐12 p40 monoclonal antibody , 2006, Inflammatory bowel diseases.

[40]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[41]  Mulin Jun Li,et al.  Nature Genetics Advance Online Publication a N a Ly S I S the Support of Human Genetic Evidence for Approved Drug Indications , 2022 .

[42]  Anne V Miller,et al.  Immunotherapies in rheumatologic disorders. , 2012, The Medical clinics of North America.

[43]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[44]  Risto Telama,et al.  Cohort profile: the cardiovascular risk in Young Finns Study. , 2008, International journal of epidemiology.

[45]  R. Bowler,et al.  Integrative omics approach identifies interleukin-16 as a biomarker of emphysema. , 2013, Omics : a journal of integrative biology.

[46]  T. Iwatsubo.  [Alzheimer's disease Neuroimaging Initiative (ADNI)]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[47]  S. Held,et al.  The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function , 2015, PloS one.

[48]  S. Cole,et al.  Genome-wide association replicates the association of Duffy antigen receptor for chemokines (DARC) polymorphisms with serum monocyte chemoattractant protein-1 (MCP-1) levels in Hispanic children. , 2012, Cytokine.

[49]  R. Vasan,et al.  Identification of cis- and trans-Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels , 2011, Circulation research.

[50]  P. D. de Bakker,et al.  Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci , 2011, Annals of neurology.

[51]  Nilanjan Chatterjee,et al.  Estimation of effect size distribution from genome-wide association studies and implications for future discoveries , 2010, Nature Genetics.

[52]  Linda Steele,et al.  Genome-Wide Association Study of Celiac Disease in North America Confirms FRMD4B as New Celiac Locus , 2014, PloS one.